Literature DB >> 32573898

Identification of hemostatic markers that define the pre-DIC state: A multi-center observational study.

Nicholas L Jackson Chornenki1,2, Dhruva J Dwivedi2, Andrew C Kwong2, Nasim Zamir2, Alison E Fox-Robichaud1,2, Patricia C Liaw1,2.   

Abstract

BACKGROUND: A limitation of diagnostic scoring systems for disseminated intravascular coagulation (DIC) is that once DIC is identified, it may be in a state of irreversible deterioration.
OBJECTIVES: To identify hemostatic markers that can identify the pre-DIC state.
METHODS: This was a multi-center observational study of 357 septic patients. The incidence of DIC was determined using the International Society on Thrombosis and Haemostasis (ISTH) DIC Score. Markers of interest include components of the DIC score: protein C (PC), antithrombin (AT), and citrullinated histones (H3Cit), which is a marker of NETosis.
RESULTS: Out of 357 sepsis patients, 236 patients did not develop DIC (without-DIC), 79 patients had DIC on Day 1 (overt-DIC), and 42 patients developed DIC after Day 1 (pre-DIC). Compared to without-DIC patients, pre-DIC patients had decreased platelet count, increased international normalized ratio (INR), decreased PC and AT, and increased H3Cit. In contrast, D-dimer and fibrinogen levels did not differ between pre-DIC and without-DIC patients. Using receiver operating characteristics (ROC) analysis, we found that platelet count and INR in combination with PC and AT could discriminate pre-DIC from without-DIC. The area under the curve in the ROC analysis was 0.83 (95% confidence interval, 0.76 to 0.89).
CONCLUSION: Our study suggests that platelets and INR in combination with PC and AT can identify the pre-DIC state in septic patients. In contrast, D-dimer increased and fibrinogen decreased in the late (ie, overt) stages of DIC. Our data also suggest that NETosis contributes to the onset of DIC in sepsis.
© 2020 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  NETosis; antithrombin; disseminated intravascular coagulation (DIC); protein C; sepsis

Mesh:

Substances:

Year:  2020        PMID: 32573898     DOI: 10.1111/jth.14973

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  8 in total

1.  Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study.

Authors:  Jaskirat Arora; Jennifer A Klowak; Sameer Parpia; Marcelo Zapata-Canivilo; Walaa Faidi; Christopher Skappak; Rachael Gregoris; Colin A Kretz; Dhruva J Dwivedi; Kerstin de Wit; Michelle Welsford; Alison Fox-Robichaud
Journal:  Crit Care Explor       Date:  2021-04-26

2.  D-dimer kit with a High FDP/D-Dimer Ratio is Useful for Diagnosing Thrombotic Diseases.

Authors:  Nozomi Ikeda; Hideo Wada; Yuhuko Ichikawa; Minoru Ezaki; Motoko Tanaka; Shinya Hiromori; Katsuya Shiraki; Isao Moritani; Akitaka Yamamoto; Hideto Shimpo; Motomu Shimaoka
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

3.  Immunothrombosis Biomarkers for Distinguishing Coronavirus Disease 2019 Patients From Noncoronavirus Disease Septic Patients With Pneumonia and for Predicting ICU Mortality.

Authors:  Erblin Cani; Dhruva J Dwivedi; Kao-Lee Liaw; Douglas D Fraser; Calvin H Yeh; Claudio Martin; Marat Slessarev; Samantha E Cerroni; Alison A Fox-Robichaud; Jeffrey I Weitz; Paul Y Kim; Patricia C Liaw
Journal:  Crit Care Explor       Date:  2021-12-02

4.  The prognostic utility of protein C as a biomarker for adult sepsis: a systematic review and meta-analysis.

Authors:  Vanessa Catenacci; Fatima Sheikh; Kush Patel; Alison E Fox-Robichaud
Journal:  Crit Care       Date:  2022-01-14       Impact factor: 9.097

Review 5.  Understanding COVID-19-associated coagulopathy.

Authors:  Edward M Conway; Nigel Mackman; Ronald Q Warren; Alisa S Wolberg; Laurent O Mosnier; Robert A Campbell; Lisa E Gralinski; Matthew T Rondina; Frank L van de Veerdonk; Karin M Hoffmeister; John H Griffin; Diane Nugent; Kyung Moon; James H Morrissey
Journal:  Nat Rev Immunol       Date:  2022-08-05       Impact factor: 108.555

Review 6.  Thromboembolic Complications of SARS-CoV-2 and Metabolic Derangements: Suggestions from Clinical Practice Evidence to Causative Agents.

Authors:  Francesco Nappi; Adelaide Iervolino; Sanjeet Singh Avtaar Singh
Journal:  Metabolites       Date:  2021-05-25

Review 7.  Recent advances in the research and management of sepsis-associated DIC.

Authors:  Toshiaki Iba; Jean Marie Connors; Isao Nagaoka; Jerrold H Levy
Journal:  Int J Hematol       Date:  2021-01-02       Impact factor: 2.490

Review 8.  Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention.

Authors:  Maria Elisa Lopes-Pires; Jéssica Oliveira Frade-Guanaes; Gregory J Quinlan
Journal:  Antioxidants (Basel)       Date:  2021-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.